• Login
Friday, April 17, 2026
Geneva Times
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
Geneva Times
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
Home Switzerland

Swiss court forces Covid vaccine procurement transparency

GenevaTimes by GenevaTimes
April 16, 2026
in Switzerland
Reading Time: 8 mins read
0
Swiss court forces Covid vaccine procurement transparency
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter


Full transparency from the FOPH on Covid-19 vaccines

Full transparency from the FOPH on Covid-19 vaccines


Keystone-SDA

The Swiss Federal Office of Public Health (FOPH) has been forced to publish unredacted contracts for procuring Covid vaccines during the pandemic.





Generated with artificial intelligence.


This content was published on


April 16, 2026 – 16:57

+Get the most important news from Switzerland in your inbox

The move follows a February court ruling that obliged the government to publish the contracts with Moderna and Navax without redactions.

The FOPH has decided not to lodge an appeal against the transparency ruling.

The plaintiffs had requested access, under the Transparency Act, to the contracts concluded by the FOPH and the army pharmacy for the Covid vaccines. This request was rejected by the Federal Office at the end of 2023.

In 2022, the FOPH published the contracts concluded with the vaccine manufacturers Moderna, Novavax, Pfizer, Janssen, AstraZeneca and CureVac only after redacting them.

The move was prompted by fears that disclosure of the contracts only in Switzerland would place Switzerland at a negotiating disadvantage when it comes to supplying vaccines in the event of a future pandemic.

Nearly a billion dollars

According to the FOPH, Switzerland was able to reserve the first 4.5 million doses of vaccine from Moderna in August 2020. By the end of the Covid pandemic, this figure had risen to 31 million doses of mRNA vaccine at a cost of around $32 per dose. This equated to a financial commitment of around $980 million.

According to the FOPH, one million doses of Novavax protein vaccine have been reserved for December 2021 at a price of $22 per dose. Switzerland paid around $20 million for these vaccines.

Adapted from German by AI/mga

We select the most relevant news for an international audience and use automatic translation tools to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication.  

Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.

If you have any questions about how we work, write to us at english@swissinfo.ch

Read More

Previous Post

Czechs Demand Explanation After Russia’s Medvedev Threatens Europe’s Drone Factories

Next Post

2026 NFL Draft: A Look Inside the Strangest Job Interview Process in Sports

Next Post
2026 NFL Draft: A Look Inside the Strangest Job Interview Process in Sports

2026 NFL Draft: A Look Inside the Strangest Job Interview Process in Sports

ADVERTISEMENT
Facebook Twitter Instagram Youtube LinkedIn

Explore the Geneva Times

  • About us
  • Contact us

Contact us:

editor@thegenevatimes.ch

Visit us

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin